| pubmed-article:16928502 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16928502 | lifeskim:mentions | umls-concept:C1709854 | lld:lifeskim |
| pubmed-article:16928502 | lifeskim:mentions | umls-concept:C0019721 | lld:lifeskim |
| pubmed-article:16928502 | lifeskim:mentions | umls-concept:C0085297 | lld:lifeskim |
| pubmed-article:16928502 | lifeskim:mentions | umls-concept:C0677582 | lld:lifeskim |
| pubmed-article:16928502 | lifeskim:mentions | umls-concept:C1325847 | lld:lifeskim |
| pubmed-article:16928502 | lifeskim:mentions | umls-concept:C0181598 | lld:lifeskim |
| pubmed-article:16928502 | lifeskim:mentions | umls-concept:C0445202 | lld:lifeskim |
| pubmed-article:16928502 | lifeskim:mentions | umls-concept:C0355642 | lld:lifeskim |
| pubmed-article:16928502 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:16928502 | pubmed:dateCreated | 2006-8-24 | lld:pubmed |
| pubmed-article:16928502 | pubmed:abstractText | The use of left ventricular assist devices is associated with human leukocyte antigen (HLA) allosensitization. We investigated whether prophylactic treatment with low-dose intravenous immunoglobulin (IVIG), analogous to the use of IgG anti-D (anti-Rh) in preventing Rh immunization, can abrogate HLA allosensitization after left ventricular assist device implantation. | lld:pubmed |
| pubmed-article:16928502 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16928502 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16928502 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16928502 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:16928502 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16928502 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16928502 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16928502 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16928502 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:16928502 | pubmed:issn | 1552-6259 | lld:pubmed |
| pubmed-article:16928502 | pubmed:author | pubmed-author:DrakosStavros... | lld:pubmed |
| pubmed-article:16928502 | pubmed:author | pubmed-author:RenlundDale... | lld:pubmed |
| pubmed-article:16928502 | pubmed:author | pubmed-author:GilbertEdward... | lld:pubmed |
| pubmed-article:16928502 | pubmed:author | pubmed-author:StringhamJame... | lld:pubmed |
| pubmed-article:16928502 | pubmed:author | pubmed-author:LongJames WJW | lld:pubmed |
| pubmed-article:16928502 | pubmed:author | pubmed-author:FullerThomas... | lld:pubmed |
| pubmed-article:16928502 | pubmed:author | pubmed-author:NelsonKarl... | lld:pubmed |
| pubmed-article:16928502 | pubmed:author | pubmed-author:KfouryAbdalla... | lld:pubmed |
| pubmed-article:16928502 | pubmed:author | pubmed-author:CampbellBever... | lld:pubmed |
| pubmed-article:16928502 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:16928502 | pubmed:volume | 82 | lld:pubmed |
| pubmed-article:16928502 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16928502 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16928502 | pubmed:pagination | 889-93 | lld:pubmed |
| pubmed-article:16928502 | pubmed:meshHeading | pubmed-meshheading:16928502... | lld:pubmed |
| pubmed-article:16928502 | pubmed:meshHeading | pubmed-meshheading:16928502... | lld:pubmed |
| pubmed-article:16928502 | pubmed:meshHeading | pubmed-meshheading:16928502... | lld:pubmed |
| pubmed-article:16928502 | pubmed:meshHeading | pubmed-meshheading:16928502... | lld:pubmed |
| pubmed-article:16928502 | pubmed:meshHeading | pubmed-meshheading:16928502... | lld:pubmed |
| pubmed-article:16928502 | pubmed:meshHeading | pubmed-meshheading:16928502... | lld:pubmed |
| pubmed-article:16928502 | pubmed:meshHeading | pubmed-meshheading:16928502... | lld:pubmed |
| pubmed-article:16928502 | pubmed:meshHeading | pubmed-meshheading:16928502... | lld:pubmed |
| pubmed-article:16928502 | pubmed:meshHeading | pubmed-meshheading:16928502... | lld:pubmed |
| pubmed-article:16928502 | pubmed:meshHeading | pubmed-meshheading:16928502... | lld:pubmed |
| pubmed-article:16928502 | pubmed:meshHeading | pubmed-meshheading:16928502... | lld:pubmed |
| pubmed-article:16928502 | pubmed:meshHeading | pubmed-meshheading:16928502... | lld:pubmed |
| pubmed-article:16928502 | pubmed:meshHeading | pubmed-meshheading:16928502... | lld:pubmed |
| pubmed-article:16928502 | pubmed:meshHeading | pubmed-meshheading:16928502... | lld:pubmed |
| pubmed-article:16928502 | pubmed:meshHeading | pubmed-meshheading:16928502... | lld:pubmed |
| pubmed-article:16928502 | pubmed:meshHeading | pubmed-meshheading:16928502... | lld:pubmed |
| pubmed-article:16928502 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16928502 | pubmed:articleTitle | Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients. | lld:pubmed |
| pubmed-article:16928502 | pubmed:affiliation | LDS Hospital, University of Utah School of Medicine, Utah Transplantation Affiliated Hospitals Cardiac Transplant Program, Salt Lake City, Utah 84143, USA. | lld:pubmed |
| pubmed-article:16928502 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16928502 | pubmed:publicationType | Evaluation Studies | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16928502 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16928502 | lld:pubmed |
